GE HealthCare announced plans to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash, expected to close in the first half of 2027.
Filing excerpt
In October 2026, the Company announced plans to acquire SOFIE Biosciences from Trilantic North America for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to customary closing conditions, including regulatory approvals.
What this signalsIntegration work after a deal often opens needs for new systems and services.
Technologies
Regions named
sec-8kacquisitionAnnouncedGet every 8-K signal for GE HealthCare and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at GE HealthCare this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/2e7a95c2-5740-4745-8e26-8c78b0cf297e returns this record as JSON. POST /v1/companies/enrich returns every signal for gehealthcare.com.
{
"signal_id": "2e7a95c2-5740-4745-8e26-8c78b0cf297e",
"signal_type": "sec-8k",
"signal_subtype": "acquisitionAnnounced",
"detected_at": "2026-11-03T07:13:10.423+00:00",
"company": {
"name": "GE HealthCare",
"domain": "gehealthcare.com"
},
"data": {
"detail": "GE HealthCare announced plans to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash, expected to close in the first half of 2027. This major integration effort may open vendor opportunities across post-merger integration, regulatory compliance, and supply chain management.",
"metrics": {
"timeframe": "next_year",
"dollar_context": "purchase price paid in cash to acquire SOFIE Biosciences",
"dollar_millions": 945
},
"summary": "GE HealthCare plans to acquire SOFIE Biosciences for $945 million in cash",
"excerpts": "In October 2026, the Company announced plans to acquire SOFIE Biosciences from Trilantic North America for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to customary closing conditions, including regulatory approvals.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1932393/000193239326000058/gehc-20261022.htm",
"filing_date": "2026-10-28",
"filing_year": 2026,
"fiscal_year_end": "10/22",
"sales_relevance": "Integration needs coming",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
],
"technologies_mentioned": [
"PET"
]
}
}
curl https://signals.autobound.ai/v1/signals/2e7a95c2-5740-4745-8e26-8c78b0cf297e \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"gehealthcare.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.